Alere

MeMed Bolsters Leadership Team With Appointment of Ori Hadomi as Chairman and Peter Scheu as President of MeMed US

Retrieved on: 
Monday, November 6, 2023

HAIFA, Israel; BOSTON, MA – 6 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter Scheu, as President of MeMed US.

Key Points: 
  • HAIFA, Israel; BOSTON, MA – 6 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Mr. Ori Hadomi as Chairman of the Board of Directors and Mr. Peter Scheu, as President of MeMed US.
  • Ori Hadomi is a renowned leader in the medical device arena, an accomplished serial entrepreneur and CEO with three decades of healthcare experience.
  • Peter Scheu is a seasoned leader with extensive experience in the healthcare and in-vitro diagnostics space.
  • Before that, he served as President North America Commercial Operations at Alere, a global provider of point-of-care diagnostics, later acquired by Abbott.

CULT Food Science Announces Artificial Intelligence Partnership for Taste Optimization in Cultivated Foods

Retrieved on: 
Thursday, June 15, 2023

Alcheme Bio's proprietary approach utilizes artificial intelligence and machine learning to revolutionize how cultured product companies optimize for flavor and nutrition.

Key Points: 
  • Alcheme Bio's proprietary approach utilizes artificial intelligence and machine learning to revolutionize how cultured product companies optimize for flavor and nutrition.
  • The outcome is products that consumers love to eat which is vital in ensuring adoption of cultivated meats, dairies and other cell-cultivated foods.
  • "Flavoring is an after-thought for most cultivated companies right now because of the limitations of today's flavoring approaches.
  • We're excited to be building out our platform in partnership with CULT."

Surfin Meta Digital Technology Pte Ltd (“Surfin”) Welcomes John Quelch and John Fennell to its Board of Directors

Retrieved on: 
Friday, April 14, 2023

Surfin group of companies (“Surfin Group”), headquartered in Singapore, a leading provider of digital financial solutions for under-serviced clients in emerging markets, is pleased to announce the appointments of John Quelch and John Fennell to its Board of Directors.

Key Points: 
  • Surfin group of companies (“Surfin Group”), headquartered in Singapore, a leading provider of digital financial solutions for under-serviced clients in emerging markets, is pleased to announce the appointments of John Quelch and John Fennell to its Board of Directors.
  • As a member of Surfin’s board of directors, Quelch brings a wealth of experience in corporate governance, strategic planning, and ESG initiatives.
  • "I am excited to join Surfin Group's board of directors and to work with the company's talented leadership team," said Quelch.
  • Yanan Wu, CFA, Ph.D, Chairman of Surfin Group, expressed the company's enthusiasm about the appointments of Dr. Quelch and Mr. Fennell: "We are thrilled to welcome both John Quelch and John Fennell to our Board of Directors.

Hospital Outsourcing Global Market Report 2022 - by Hospital Type, Hospital Size, Services, End-Users and Region

Retrieved on: 
Friday, January 13, 2023

DUBLIN, Jan. 13, 2023 /PRNewswire/ -- The "Hospital Outsourcing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Jan. 13, 2023 /PRNewswire/ -- The "Hospital Outsourcing Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.
  • This report provides strategists, marketers and senior management with the critical information they need to assess the global hospital outsourcing market.
  • The regions covered in the hospital outsourcing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
  • The hospital outsourcing market research report is one of a series of new reports that provides hospital outsourcing market statistics, including hospital outsourcing industry global market size, regional shares, competitors with a hospital outsourcing market share, detailed hospital outsourcing market segments, market trends and opportunities, and any further data you may need to thrive in the hospital outsourcing industry.

Wolters Kluwer Tax & Accounting names Garrett Hale EVP, Global Operations

Retrieved on: 
Tuesday, January 17, 2023

Wolters Kluwer (Euronext: WKL), a leading provider of expert solutions, insights and services for professionals, today announced the appointment of Garrett Hale as Executive Vice President, Global Operations for Wolters Kluwer Tax & Accounting.

Key Points: 
  • Wolters Kluwer (Euronext: WKL), a leading provider of expert solutions, insights and services for professionals, today announced the appointment of Garrett Hale as Executive Vice President, Global Operations for Wolters Kluwer Tax & Accounting.
  • Based in Atlanta, Mr. Hale is responsible for the business operations and customer service for the Dutch-based technology company’s Tax & Accounting division.
  • “We are thrilled to welcome Garrett Hale to Wolters Kluwer Tax & Accounting as our new Executive Vice President, Global Operations,” says Karen Abramson, Chief Executive Officer, Wolters Kluwer Tax & Accounting.
  • “Wolters Kluwer Tax & Accounting has a long history of success and a portfolio of innovative solutions,” says Hale.

Quanterix Announces Appointment of Brian Blaser to Board of Directors

Retrieved on: 
Monday, January 9, 2023

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has appointed Brian Blaser to its Board of Directors effective as of January 6, 2023.

Key Points: 
  • Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that it has appointed Brian Blaser to its Board of Directors effective as of January 6, 2023.
  • “Throughout his career, Brian has defined and implemented transformational strategies to accelerate growth, increase scale, and dramatically improve profitability,” said Masoud Toloue, CEO at Quanterix.
  • Mr. Blaser has also served on the Board of Directors for AdvaMed.
  • “On behalf of the entire board, I am delighted that Brian has decided to step into this new role.”
    To learn more about Quanterix, visit www.quanterix.com/about .

QuidelOrtho Announces Separation of Chairman and Chief Executive Officer Roles

Retrieved on: 
Monday, December 12, 2022

The separation of the Chairman and Chief Executive Officer roles is a key step toward strengthening the Companys governance practices and will facilitate the right balance between strong and consistent Company leadership and independent oversight by the Board.

Key Points: 
  • The separation of the Chairman and Chief Executive Officer roles is a key step toward strengthening the Companys governance practices and will facilitate the right balance between strong and consistent Company leadership and independent oversight by the Board.
  • The Board also appointed Douglas Bryant to serve as President, in addition to Mr. Bryants current role as Chief Executive Officer and a member of the Board.
  • He brings strategic oversight combined with a wealth of leadership and scientific industry expertise to our Board, said Mr. Bryant, President and Chief Executive Officer of QuidelOrtho.
  • Additionally, Robert J. Bujarski, Chief Operating Officer, and Michael S. Iskra, Chief Commercial Officer, have both been appointed to the newly created Executive Vice President roles, in addition to serving in their existing leadership roles.

Sapphiros Appoints Mark Gladwell as CEO and President

Retrieved on: 
Thursday, October 27, 2022

BOSTON, Oct. 27, 2022 /PRNewswire/ -- Sapphiros, a platform dedicated to building the next generation of consumer diagnostic technologies, today announced the promotion of Mark Gladwell, Sapphiros's Chief Operating Officer ("COO") to President and Chief Executive Officer ("CEO").

Key Points: 
  • BOSTON, Oct. 27, 2022 /PRNewswire/ -- Sapphiros, a platform dedicated to building the next generation of consumer diagnostic technologies, today announced the promotion of Mark Gladwell, Sapphiros's Chief Operating Officer ("COO") to President and Chief Executive Officer ("CEO").
  • Namal Nawana, Sapphiros Executive Chairman and Founder, said, "Sapphiros has achieved meaningful scale through a series of foundational acquisitions and will launch multiple new product platforms and partnerships in the near term.
  • Mark brings over 25 years of experience in the medical device and diagnostics industries to Sapphiros.
  • It's an honour to be appointed as the CEO of Sapphiros to lead the company through this exciting expansion phase."

Sapphiros Appoints Mark Gladwell as CEO and President

Retrieved on: 
Thursday, October 27, 2022

BOSTON, Oct. 27, 2022 /PRNewswire/ -- Sapphiros, a platform dedicated to building the next generation of consumer diagnostic technologies, today announced the promotion of Mark Gladwell, Sapphiros's Chief Operating Officer ("COO") to President and Chief Executive Officer ("CEO").

Key Points: 
  • BOSTON, Oct. 27, 2022 /PRNewswire/ -- Sapphiros, a platform dedicated to building the next generation of consumer diagnostic technologies, today announced the promotion of Mark Gladwell, Sapphiros's Chief Operating Officer ("COO") to President and Chief Executive Officer ("CEO").
  • Namal Nawana, Sapphiros Executive Chairman and Founder, said, "Sapphiros has achieved meaningful scale through a series of foundational acquisitions and will launch multiple new product platforms and partnerships in the near term.
  • Mark brings over 25 years of experience in the medical device and diagnostics industries to Sapphiros.
  • It's an honour to be appointed as the CEO of Sapphiros to lead the company through this exciting expansion phase."

COVID-19 Will Be With Us For Years, So Will a Large In Vitro Diagnostics Market

Retrieved on: 
Wednesday, August 31, 2022

 ARLINGTON, Va., Aug. 31, 2022 /PRNewswire/ -- The worldwide in vitro diagnostic (IVD) market will reach $127.4 billion dollars in 2022, according to IVD market research firm Kalorama Information.  That's the finding from the firm's 15th large-scale IVD industry report, The Worldwide Market for In Vitro Diagnostic Tests, released this month. The market will grow to $140.1 billion in 2027, and COVID-19 testing will drive that market. The larger part of the IVD market is non-COVID testing and diabetes and cancer testing products, which will also drive the industry to growth.  

Key Points: 
  • That's the finding from the firm's 15th large-scale IVD industry report, The Worldwide Market for In Vitro Diagnostic Tests , released this month.
  • The market will grow to $140.1 billion in 2027, and COVID-19 testing will drive that market.
  • Kalorama has called the IVD market for two decades in detailed reports based on company financial information, interviews and medical statistics (FOR MORE INFORMATION: https://kaloramainformation.com/product/the-worldwide-market-for-in-vitr... ).
  • But the bulk of the market sales in 2022, an estimated $94.8 billion, will be from non-COVID-19 IVD tests.